Tasly Pharmaceutical Group Co., Ltd

XSSC:600535 Stock Report

Market Cap: CN¥21.6b

Tasly Pharmaceutical Group Future Growth

Future criteria checks 2/6

Tasly Pharmaceutical Group is forecast to grow earnings and revenue by 22.7% and 6.9% per annum respectively. EPS is expected to grow by 22.8% per annum. Return on equity is forecast to be 10.1% in 3 years.

Key information

22.7%

Earnings growth rate

22.8%

EPS growth rate

Pharmaceuticals earnings growth18.8%
Revenue growth rate6.9%
Future return on equity10.1%
Analyst coverage

Good

Last updated08 Nov 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

XSSC:600535 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202610,0741,489N/A1,9198
12/31/20259,4241,305N/A1,5288
12/31/20248,9111,021N/A1,4048
9/30/20248,5658812,0332,676N/A
6/30/20248,6541,0262,0502,621N/A
3/31/20248,6381,1021,5512,088N/A
12/31/20238,6741,0711,9072,576N/A
9/30/20239,0761,1121,7682,287N/A
6/30/20238,9968591,9502,496N/A
3/31/20238,8475581,7872,347N/A
12/31/20228,637-2641,8752,280N/A
9/30/20228,3155341,3131,803N/A
6/30/20228,1599401,3561,782N/A
3/31/20228,0631,4781,9642,480N/A
12/31/20217,9522,3592,2292,801N/A
9/30/20217,9551,5072,2492,739N/A
6/30/20218,7791,4421,6152,145N/A
3/31/202111,3871,1541,7362,163N/A
12/31/202013,5761,1261,3821,791N/A
9/30/202016,2989699661,550N/A
6/30/202018,2057891,4672,102N/A
3/31/202018,3808487641,455N/A
12/31/201918,9981,0019491,680N/A
9/30/201919,0571,3087701,597N/A
6/30/201918,9311,5198751,718N/A
3/31/201918,6091,6227961,601N/A
12/31/201817,9901,5457141,494N/A
9/30/201817,9571,6079071,432N/A
6/30/201817,3061,545N/A1,023N/A
3/31/201816,6991,430N/A75N/A
12/31/201716,0941,377N/A-796N/A
9/30/201715,4971,312N/A-637N/A
6/30/201714,8111,248N/A-692N/A
3/31/201714,1481,218N/A298N/A
12/31/201613,9451,176N/A1,154N/A
9/30/201613,4541,263N/A759N/A
6/30/201613,3911,333N/A840N/A
3/31/201613,2941,410N/A502N/A
12/31/201513,2281,479N/A340N/A
9/30/201512,7421,447N/A351N/A
6/30/201512,6981,454N/A326N/A
3/31/201512,6401,429N/A326N/A
12/31/201412,5781,368N/A617N/A
9/30/201412,2341,335N/A810N/A
6/30/201411,8161,242N/A602N/A
3/31/201411,3941,138N/A480N/A
12/31/201311,1081,098N/A345N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 600535's forecast earnings growth (22.7% per year) is above the savings rate (2.8%).

Earnings vs Market: 600535's earnings (22.7% per year) are forecast to grow slower than the CN market (26.2% per year).

High Growth Earnings: 600535's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 600535's revenue (6.9% per year) is forecast to grow slower than the CN market (13.9% per year).

High Growth Revenue: 600535's revenue (6.9% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 600535's Return on Equity is forecast to be low in 3 years time (10.1%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y